Hiroki Kawabata

Wakayama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Preoperative Tumor Shape Irregularity Is Associated With Pathological Upstaging to pT3 in Clinical T1 Renal Cell Carcinoma Treated With Partial or Radical Nephrectomy.

Preoperative Tumor Shape Irregularity Is Associated With Pathological Upstaging to pT3 in Clinical T1 Renal Cell Carcinoma Treated With Partial or Radical Nephrectomy.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: April 14, 2026

Comparison of the da Vinci Xi and hinotori surgical robotic systems using a training model: an ex vivo study.

Comparison of the da Vinci Xi and hinotori surgical robotic systems using a training model: an ex vivo study.

Journal: Journal of robotic surgery

Published: December 09, 2025

Salvage Surgery for Primary Renal Pelvic Urothelial Carcinoma After Enfortumab Vedotin: A Case of Durable Remission With Nectin-4 Loss.

Salvage Surgery for Primary Renal Pelvic Urothelial Carcinoma After Enfortumab Vedotin: A Case of Durable Remission With Nectin-4 Loss.

Journal: IJU case reports

Published: August 23, 2025

Synchronous Bilateral Large Renal Cell Carcinoma Treated With Presurgical Pembrolizumab and Lenvatinib Enabling Unilateral Partial Nephrectomy and Dialysis Avoidance: A Case Report.

Synchronous Bilateral Large Renal Cell Carcinoma Treated With Presurgical Pembrolizumab and Lenvatinib Enabling Unilateral Partial Nephrectomy and Dialysis Avoidance: A Case Report.

Journal: IJU case reports

Published: June 21, 2025

TMB-High, MSI-High Castration-Resistant Prostate Cancer Treated With Pembrolizumab.

TMB-High, MSI-High Castration-Resistant Prostate Cancer Treated With Pembrolizumab.

Journal: IJU case reports

Published: March 10, 2025

Pembrolizumab Plus Lenvatinib for Metastatic Renal Cell Carcinoma in a Patient on Hemodialysis.

Pembrolizumab Plus Lenvatinib for Metastatic Renal Cell Carcinoma in a Patient on Hemodialysis.

Journal: IJU case reports

Published: February 03, 2025

The Impact of Visceral Fat Accumulation on 24-h Urine Chemistries and Stone-Recurrence in Patients With Urolithiasis.

The Impact of Visceral Fat Accumulation on 24-h Urine Chemistries and Stone-Recurrence in Patients With Urolithiasis.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: November 30, 2024

Comparison of Prognosis and Health-Related Quality of Life Between Robot-Assisted Radical Prostatectomy Versus High-Dose-Rate Brachytherapy Combined With External Beam Radiation Therapy and Hormone Therapy for High-Risk Prostate Cancer.

Comparison of Prognosis and Health-Related Quality of Life Between Robot-Assisted Radical Prostatectomy Versus High-Dose-Rate Brachytherapy Combined With External Beam Radiation Therapy and Hormone Therapy for High-Risk Prostate Cancer.

Journal: The Prostate

Published: July 18, 2024

Verification of surgical factors affecting the efficiency of stone extraction with one-surgeon basketing technique using a f-URSL simulation model.

Verification of surgical factors affecting the efficiency of stone extraction with one-surgeon basketing technique using a f-URSL simulation model.

Journal: Investigative and clinical urology

Published: March 12, 2024

Poor performance status is a risk factor for higher detection of Gram positive coccus in stone-related pyelonephritis.

Poor performance status is a risk factor for higher detection of Gram positive coccus in stone-related pyelonephritis.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: August 16, 2023

Strain accumulation and release associated with the occurrence of SSEs in the subduction zones of the Japanese Islands.

Strain accumulation and release associated with the occurrence of SSEs in the subduction zones of the Japanese Islands.

Journal: Scientific reports

Published: May 05, 2022

A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG2a-f) Exerts Antitumor Activity in a Mouse Xenograft Model of Renal Cell Cancers.

A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG2a-f) Exerts Antitumor Activity in a Mouse Xenograft Model of Renal Cell Cancers.

Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy

Published: April 28, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026